Page last updated: 2024-10-20

thymine and Astrocytoma, Grade IV

thymine has been researched along with Astrocytoma, Grade IV in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin."5.91Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. ( Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023)
"Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin."1.91Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. ( Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ziganshina, AY1
Mansurova, EE1
Voloshina, AD1
Lyubina, AP1
Amerhanova, SK1
Shulaeva, MM1
Nizameev, IR1
Kadirov, MK1
Bakhtiozina, LR1
Semenov, VE1
Antipin, IS1

Other Studies

1 other study available for thymine and Astrocytoma, Grade IV

ArticleYear
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells.
    Molecules (Basel, Switzerland), 2023, Jan-05, Volume: 28, Issue:2

    Topics: Antineoplastic Agents; Brain Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Glioblast

2023